Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

First Antisense Drug for Chemotherapy-Responsive Chronic Lymphocytic Leukemia

Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on February 19, 2007

First Antisense Drug for Chemotherapy-Responsive Chronic Lymphocytic Leukemia
A phase III clinical trial for oblimersen (trade name: Genasense), the first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL), shows promise as an adjunct therapy to chemotherapy drug fludarabine.
Oblimersen is an experimental agent that inhibits the production of a proteinlinks known as Bcl-2 in cancer cells. This protein can stop a cell from destroying itself, and is often over-expressed in cancer. As an antisense drug, oblimersen provides a complementary genetic strand to the messenger RNA that produces Bcl-2, inactivating it and preventing the protein from being produced. "It gets rid of Bcl-2, and cells that have less Bcl-2 are more sensitive to chemotherapy," O'Brien says.

According to the results, oblimersen produced a four-fold increase in CP/nPR, a clinical response defined by no definitive evidence of disease among patients who were sensitive to the chemotherapy drug fludarabine. In addition, survival was found to be three or more years in 70 percent of the patients in the oblimersen group compared with 38% in the chemotherapy-alone group. According to the researchers, oblimersen may represent a new treatment option for this subset of CLL patients whose disease has progressed, but who are still sensitive to chemotherapy.

Source: UT MD Anderson Cancer Center






Permalink: First Antisense Drug for Chemotherapy-Responsive Chronic Lymphocytic Leukemia
Tags: leukemia  antisense  gene+therapy  biotech  drug  antisense+drug  lymphocytic+leukemia  first+antisense 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/54283





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells